Nanotags enable the detection of pancreatic cancer in the blood
Pancreatic cancer is one of the deadliest forms of cancer, with the 5-year survival rate in men and women at around 3%. The symptoms are subtle – if they are even present – and therefore, the diagnosis of pancreatic cancer is extremely difficult. Recently, a paper published in American Chemical Society Sensors reports the use of plasmonic nanoparticles to successfully detect signs of pancreatic cancer in the blood of patients who are currently undergoing treatment for the disease. "The test gave a very high signal in the blood for late-stage or very serious tumors, where other techniques cannot detect anything,"...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
